Metabolic syndrome (MetS) is defined as a cluster of clinical markers which increases the risk of cardiovascular disease. These include elevated fasting blood glucose, elevated blood pressure, increased plasma triglycerides, reduced high-density lipoprotein cholesterol and central obesity. There exist many definitions for MetS with varying prerequisites and clinical measurement parameters, which can influence the diagnosis. MetS is associated with an increased risk of cardiovascular disease, the leading cause of death in Ireland, and an increase in risk of developing type 2 diabetes. Lifestyle changes such as diet, physical activity and sleep hygiene have been shown to be beneficial at preventing and treating MetS. Medication is often prescribed to manage individual clinical markers. Therefore, this project aims to investigate the current treatment strategies of MetS in the Irish primary care environment. Of interest are what specific lifestyle recommendations are being advised and which medications are most commonly prescribed.

Supervisors: Dr Geraldine Cuskelly and Dr Mary McDonnell Naughton